Table 1.
Baseline characteristic of CAD and non-CAD cohorts and serum soluble TREM2 levels.
| CAD (n = 230) |
Non-CAD (n = 53) |
|
|---|---|---|
| sTREM2 (pg/mL) | 9115 ± 5969 | 8049± 4518 |
| Age (years) | 67 ± 12 | 65 ± 14 |
| Male | 152 (66%) | 33 (63%) |
| BMI (kg/m2) | 28.9 ± 5.4 | 28.1 ± 6.0 |
| Diabetes mellitus | 92 (40.0%) | 18 (34.0%) |
| Hypertension | 172 (74.8%) | 34 (64.2%) |
| Hyperlipidemia | 158 (68.7%) | 26 (49.1%) |
| Smoking (current) | 42 (18.3%) | 10 (18.9%) |
| PVD | 10 (4.4%) | 1 (1.8%) |
| CVA | 19 (8.3%) | 3 (5.7%) |
| Chronic renal failure | 44 (19.1%) | 8 (15.1%) |
Baseline characteristics classified according to significant CAD (>70% stenosis on coronary angiography). PVD, peripheral vascular disease; CVA, cerebrovascular accident; BMI, Body mass index; sTREM2, soluble TREM2. Values are expressed as either number (%) or mean ± SD.